Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Atopic Dermatitis Treatment Market Outlook

The market for atopic dermatitis treatment reached about USD 11.43 billion in 2023. The industry is further expected to grow at a CAGR of about 8.6% in the forecast period of 2024-2032. It will reach an approximate value of USD 24.07 billion by the end of 2032, driven by the rising awareness about the importance of treatment among the people.

atopic-dermatitis-treatment-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America is Leading the Atopic Dermatitis Treatment Market

North America is expected to hold a significant share of the global atopic dermatitis market. The influencing factors include the growing number of people suffering from skin disorders, rapid climate changes, the thriving population and increasing disposable income. The increasing awareness about the importance of treatment is making people more inclined to follow the procedures and get the cure, which increases the significance of the atopic dermatitis treatment market.

The United States and Canada have well-established and advanced healthcare infrastructures. With the early adoption of novel prescriptions and improved and favourable reimbursement regulations, it is made possible for patients to go for the services provided without facing any burdens. Furthermore, pharmaceutical companies are growing their business relations with research organisations to target the developing region by increasing their investments in R&D to make advancements and focus on launching new products. With the technological advances and the introduction of new procedures in the medical field, the market is likely to grow further in the coming years.

Market Segmentation: Atopic Dermatitis Treatment Market

Atopic dermatitis, also known as eczema, is a skin condition where the patient's skin gets red, itchy, dry, and bumpy. It usually develops in early childhood but can occur at any age, and the likelihood of getting dermatitis increases if the person's family has a genetic history of atopic dermatitis.

atopic-dermatitis-treatment-market-by-segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The market for atopic dermatitis treatment, by drug class, can be broadly divided into:

  • Corticosteroids
  • Calcineurin Inhibitors
  • Immunosuppressant
  • Biologic Therapy
  • PDE-4 Inhibitor
  • Antibiotics
  • Antihistamines
  • Emollients

The modes of administration in the market are as follows:

  • Topical
  • Oral
  • Injectable

By distribution channels, the market for atopic dermatitis treatment can be divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Dermatology Clinics
  • Others

Regional atopic disease treatment markets can be divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

atopic-dermatitis-treatment-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The Rising Initiatives to Spread Awareness About Treatments are Driving the Market

Skin problems like allergies and chronic disorders are increasing, and with the rapid climate changes, these disorders will not slow down anytime soon. Growing investments in healthcare can accelerate the market's growth as the dermatology sector has been rising rapidly. Medical Organizations are collaborating with the governments to develop new procedures and policies, equipping the institutes with state-of-the-art technology to support the increasing number of patients and let them avail the treatments easily, which shows promising growth for the market.

The key players are focusing on mergers and collaborations with leading players of foreign regions to build their presence in foreign markets and make product advancements with the collaborative effort. They are creating novel prescriptions and cost-effective treatments for the developing countries and people who are unable to afford to top of the line options. The thriving population of countries like China and India having a massive population shows excellent scope for growth of the atopic dermatitis treatment market.

Key Players in the Global Market for Atopic Dermatitis Treatment

The report gives a detailed analysis of the following key players in the global atopic dermatitis treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, investments, expansions of capacity, and plant turnarounds:

  • Pfizer Inc.
  • Astellas Pharma Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Mode of Administration
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Corticosteroids
  • Calcineurin Inhibitors
  • Immunosuppressant
  • Biologic Therapy
  • PDE-4 Inhibitor
  • Antibiotics
  • Antihistamines
  • Emollients
Breakup by Mode of Administration
  • Topical
  • Oral
  • Injectable
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Dermatology Clinics
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global district heating market attained a value of nearly USD 11.43 billion.

The market is projected to grow at a CAGR of 8.6% between 2024 and 2032.

The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 24.07 billion by 2032.

The primary industry drivers include the rising dermatology sector, increasing initiatives to spread awareness about the treatment, and the rising competition among the key players.

The collaboration with the government to improvise the policies and procedures of the treatment is a key driver propelling market growth.

The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America being the most prominent market region.

In the atopic dermatitis treatment, the drug class can be divided into Corticosteroids, Calcineurin inhibitors, immunosuppressants, Biologic Therapy, PDE-4 inhibitors, antibiotics, antihistamines, and emollients.

The modes of administration can be segmented into topical, oral, and injectable.

The distribution channels of the market include hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and dermatology clinics, among others.

The major players in the industry are Pfizer Inc., Astellas Pharma Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi SA, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124